Patent ID: 11919906
Assignee: HANGZHOU SOLIPHARMA CO., LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 0:
1. A method of treating a B cell proliferative disease comprising administering to a subject in need of treatment, a composition comprising a therapeutically effective amount of ACP-196 Form 2, having the chemical structure:, , or a pharmaceutically acceptable salt thereof, wherein, measured using Cu-Kα radiation, the X-ray powder diffraction pattern of the ACP-196 Form 2, expressed as 2θ angles, has the following characteristic peaks: 7.4±0.2°, 8.3±0.2°, 10.3±0.2°, 12.4±0.2°, 12.7±0.2°, 13.9±0.2°, 14.9±0.2°, 17.8±0.2°, 21.9±0.2°, 23.2±0.2°, 24.3±0.2° and 24.9±0.2°.